Page last updated: 2024-08-24

ranolazine and Diabetic Neuropathies

ranolazine has been researched along with Diabetic Neuropathies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
El-Gawly, HW; El-Sherbeeny, NA; Elaidy, SM; Elkholy, SE; Toraih, EA	1

Other Studies

1 other study(ies) available for ranolazine and Diabetic Neuropathies

Article	Year
Neuroprotective effects of ranolazine versus pioglitazone in experimental diabetic neuropathy: Targeting Nav1.7 channels and PPAR-γ. Life sciences, 2020, Jun-01, Volume: 250 Topics: Animals; Behavior, Animal; Comorbidity; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Diet, High-Fat; Hyperalgesia; Inflammation; Interleukin-1beta; Male; NAV1.7 Voltage-Gated Sodium Channel; Neuroprotective Agents; Pioglitazone; PPAR gamma; Ranolazine; Rats; Rats, Wistar; Spinal Cord; Tumor Necrosis Factor-alpha	2020

Article

Year

Neuroprotective effects of ranolazine versus pioglitazone in experimental diabetic neuropathy: Targeting Nav1.7 channels and PPAR-γ.

Life sciences, 2020, Jun-01, Volume: 250

Topics: Animals; Behavior, Animal; Comorbidity; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Diet, High-Fat; Hyperalgesia; Inflammation; Interleukin-1beta; Male; NAV1.7 Voltage-Gated Sodium Channel; Neuroprotective Agents; Pioglitazone; PPAR gamma; Ranolazine; Rats; Rats, Wistar; Spinal Cord; Tumor Necrosis Factor-alpha

2020